Cargando…

NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide and its incidence is definitely increasing. NAFLD is a metabolic disease with extensive multi-organ involvement, whose extra-hepatic manifestations include type 2 diabetes mellitus, cardiovascular di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosato, Valerio, Masarone, Mario, Dallio, Marcello, Federico, Alessandro, Aglitti, Andrea, Persico, Marcello
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6765902/ https://www.ncbi.nlm.nih.gov/pubmed/31540048 http://dx.doi.org/10.3390/ijerph16183415

Ejemplares similares

Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease
por: Masarone, Mario, et al.
Publicado: (2018)

Vascular Endothelial Dysfunction in Inflammatory Bowel Diseases: Pharmacological and Nonpharmacological Targets
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2018)

Corrigendum to “Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease”
por: Masarone, Mario, et al.
Publicado: (2021)

Rapid Virological Response Represents the Highest Prediction Factor of Response to Antiviral Treatment in HCV-Related Chronic Hepatitis: a Multicenter Retrospective Study
por: Federico, Alessandro, et al.
Publicado: (2015)

The Role of Fructose in Non-Alcoholic Steatohepatitis: Old Relationship and New Insights
por: Federico, Alessandro, et al.
Publicado: (2021)

Viral hepatitis: Milestones, unresolved issues, and future goals
por: Torre, Pietro, et al.
Publicado: (2021)

The effect of antiviral therapy on hepatitis C virus-related thrombocytopenia: a case report
por: Lebano, Rita, et al.
Publicado: (2014)

Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage
por: Masarone, Mario, et al.
Publicado: (2017)

PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial
por: Dallio, Marcello, et al.
Publicado: (2021)

The Role of Resveratrol in Liver Disease: A Comprehensive Review from In Vitro to Clinical Trials
por: Izzo, Carmine, et al.
Publicado: (2021)

Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis
por: Federico, Alessandro, et al.
Publicado: (2017)

Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives
por: Dallio, Marcello, et al.
Publicado: (2021)

Correction to: “Non alcoholic fatty liver disease and eNOS dysfunction in humans”
por: Persico, Marcello, et al.
Publicado: (2017)

“Non alcoholic fatty liver disease and eNOS dysfunction in humans”
por: Persico, Marcello, et al.
Publicado: (2017)

The Bisphenol A Induced Oxidative Stress in Non-Alcoholic Fatty Liver Disease Male Patients: A Clinical Strategy to Antagonize the Progression of the Disease
por: Federico, Alessandro, et al.
Publicado: (2020)

Characterisation of asymptomatic patients and efficacy of preventive measures for SARS-CoV-2 infection in a large population of Southern Italy: a cohort study
por: Masarone, Mario, et al.
Publicado: (2021)

Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients
por: Federico, Alessandro, et al.
Publicado: (2019)

Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System
por: Torre, Pietro, et al.
Publicado: (2021)

Coeliac disease and C virus-related chronic hepatitis: a non association
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2012)

The Role of Insulin Resistance in Fueling NAFLD Pathogenesis: From Molecular Mechanisms to Clinical Implications
por: Palma, Rossella, et al.
Publicado: (2022)

Hepatitis C screening during SARS‐CoV‐2 testing or vaccination. Experience in an area of southern Italy in the province of Salerno
por: Torre, Pietro, et al.
Publicado: (2022)

Chemical Effect of Bisphenol A on Non-Alcoholic Fatty Liver Disease
por: Dallio, Marcello, et al.
Publicado: (2019)

Country-Wide HCV Elimination Strategies Need to Reach Older Patients in the General Population: The Italian Experience
por: Torre, Pietro, et al.
Publicado: (2023)

Extra-Gastric Manifestations of Helicobacter pylori Infection
por: Gravina, Antonietta G., et al.
Publicado: (2020)

From Non-Alcoholic Steatohepatitis (NASH) to Hepatocellular Carcinoma (HCC): Epidemiology, Incidence, Predictions, Risk Factors, and Prevention
por: Motta, Benedetta Maria, et al.
Publicado: (2023)

Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma
por: Masarone, Mario, et al.
Publicado: (2014)

Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
por: Federico, Alessandro, et al.
Publicado: (2017)

NAFLD or comorbidities, that is the question
por: Ponziani, Francesca Romana, et al.
Publicado: (2020)

Comorbidities and Metabolic Derangement of NAFLD
por: Bang, Ki Bae, et al.
Publicado: (2015)

Reply to: ‘NAFLD or comorbidities, that is the question’
por: Ji, Dong, et al.
Publicado: (2020)

Chitosan-coated liposomes loaded with butyric acid demonstrate anticancer and anti-inflammatory activity in human hepatoma HepG2 cells
por: Quagliariello, Vincenzo, et al.
Publicado: (2019)

Screening for HCV infection combined with SARS-CoV-2 vaccination in the Campania region
por: Torre, Pietro, et al.
Publicado: (2022)

Novel Insights into the Genetic Landscape of Nonalcoholic Fatty Liver Disease
por: Taliento, Alice Emma, et al.
Publicado: (2019)

Pharmacological Therapy of Non-Alcoholic Fatty Liver Disease: What Drugs Are Available Now and Future Perspectives
por: Pennisi, Grazia, et al.
Publicado: (2019)

Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2020)

Current Management of NAFLD
por: MUNTEANU, MIHAI ALEXANDRU, et al.
Publicado: (2016)

Associated screening for HCV and SARS‐Cov2 infection in an urban area of Southern Italy: A cohort study
por: Coppola, Carmine, et al.
Publicado: (2021)

Immunity as Cornerstone of Non-Alcoholic Fatty Liver Disease: The Contribution of Oxidative Stress in the Disease Progression
por: Dallio, Marcello, et al.
Publicado: (2021)

NAFLD/MAFLD: New Evidence
por: Mantovani, Alessandro, et al.
Publicado: (2023)

Screening, Linkage to Care and Treatment of Hepatitis C Infection in Primary Care Setting in the South of Italy
por: Citarella, Anna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fpv56m1embpjsv80q2gkfup1u2